Think Research Corporation V.THNK

Healthcare Medical Devices

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.

TSXV:THNK - Post by User

Think Research Corporation > Let's see if this works. Trying to post the results:

<< Previous

Bullboard Posts

Next >>

Comment by AlwaysLong683on May 30, 2022 7:09am

88 Views

Post# 34716266

RE:RE:RE:Let's see if this works. Trying to post the results:

Not sure how reliable the quoted numbers are.

PR from THNK's own website:

TORONTO, ON – May 26, 2022 —

Think Research Corporation (TSXV:THNK)(OTC: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it will release its financial results for the three months ended March 31, 2022 before the market opens on May 30, 2022.

Think’s financial statements and Management Discussion and Analysis will be available under the Company’s profile on SEDAR and on the Company’s website as of 7:30 a.m. Eastern Time.

Management will hold a conference call on May 30, 2022 at 9 a.m. Eastern Time hosted by CEO Sachin Aggarwal and interim CFO John Hayes with a Q&A session to follow.

Conference call dial-in:

Toronto: 416-764-8659

North American Toll-free: 1-888-664-6392

Conference ID: 11593959

Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1551355&tp_key=9f0d8e674c

A transcript of the call will be posted on the Company’s website at www.thinkresearch.com within 48 hours of the call.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports